HOME
                
				
				
                
                 keyboard_arrow_right 
              	產品介紹
                 keyboard_arrow_right 
                生技服務
                 keyboard_arrow_right 
                細胞代工量產服務
                 keyboard_arrow_right 
                CDMO Service                     
                  
            
        
                        CDMO Service
                    
    
                     
                          
                               	GenCure 為創新療法領域提供各種支援服務,包含製程、檢驗分析開發、cGMP 生產、
製程確效及最終產品放行測試,同時藉由統一的品質管理系統,與客戶一同實現臨床
應用及產品商業化的目標。
            
                        製程確效及最終產品放行測試,同時藉由統一的品質管理系統,與客戶一同實現臨床
應用及產品商業化的目標。
                                服務項目
                                
                                
                            
                            
                            - 服務項目
| Custom Source Materials | 
Access to cGMP and cGTP products for transfusion and transplant; cGMP for further manufacture in development selectively
| ● Perinatal tissues | ● Bone marrow-derived stem cells | 
| ● Umbilical cord blood | ● Apheresis derived progenitor cells | 
| ● Blood components | ● Mononuclear cells | 
| Development | 
Transfer, development and optimization of cGMP-compliant scalable processes
| ● Cell therapy process development | ● Scale-up | 
| ● Cell isolation | ● Downstream purification | 
| ● Cell expansion | ● Formulation development | 
| ● Cryopreservation | 
| Manufacturing | 
cGMP-compliant, phase-appropriate, manufacturing of advanced therapies
| ● Pre-clinical | ● Late phase and commercial | 
| ● Early phase clinical-grade | ● Fill/Finish | 
| Testing | 
cGXP testing services performed internally and through qualified partners
| ● Sterility testing (ID and susceptibility) | ● Cell viabtiliy | 
| ● Viral safety testing | ● Identity/purity testing | 
| ● Cell characterization and authentication | ● Custom assay development | 
| ● Potency testing | ● Method suitability | 
| ● Lot and final product release testing | ● Plasma, blood, cord blood, tissue and organ donor safety testing | 
| Storage and Logistics | 
Management of cold chain processes for final products
| ● Optimization of controlled-rate freezing | 
| ● Storage of products (LN2 vapor-phase, 2-8° C, -20° C, -80° C) | 
| ● Validated shipping procedures | 
| ● Continuous temperature monitoring during shipping | 
| ● Maintenance of samples for stability testing | 
